Literature DB >> 3535798

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

P Westermark, C Wernstedt, E Wilander, K Sletten.   

Abstract

Deposition of amyloid is the most constantly present alteration in the islets of Langerhans in type 2 diabetes mellitus and is also quite common in insulin-producing tumors of the pancreas and it is very likely that these two amyloids are identical. We have isolated amyloid fibrils from an insulin-secreting human tumour and purified the fibrillar protein. N-terminal amino acid sequence of the protein is unique and does not resemble insulin or its precursors. Instead it has about 50% homology with the neuropeptide CGRP (calcitonin gene related peptide).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535798     DOI: 10.1016/0006-291x(86)90708-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  105 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation.

Authors:  Fanling Meng; Andisheh Abedini; Annette Plesner; Chris T Middleton; Kathryn J Potter; Martin T Zanni; C Bruce Verchere; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-05-07       Impact factor: 5.469

3.  Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.

Authors:  Tatsuo Tomita
Journal:  Islets       Date:  2011-07-01       Impact factor: 2.694

Review 4.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

5.  Insulin secretory granule biogenesis. Co-ordinate regulation of the biosynthesis of the majority of constituent proteins.

Authors:  P C Guest; E M Bailyes; N G Rutherford; J C Hutton
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

6.  Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates.

Authors:  Fanling Meng; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-12-30       Impact factor: 5.469

7.  Crystal Structures of IAPP Amyloidogenic Segments Reveal a Novel Packing Motif of Out-of-Register Beta Sheets.

Authors:  Angela B Soriaga; Smriti Sangwan; Ramsay Macdonald; Michael R Sawaya; David Eisenberg
Journal:  J Phys Chem B       Date:  2016-01-11       Impact factor: 2.991

8.  Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets.

Authors:  A Lukinius; E Wilander; G T Westermark; U Engström; P Westermark
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

9.  Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.

Authors:  B Ludvik; M Clodi; A Kautzky-Willer; M Schuller; H Graf; E Hartter; G Pacini; R Prager
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Cyclic N-terminal loop of amylin forms non amyloid fibers.

Authors:  Stephanie M Cope; Sandip Shinde; Robert B Best; Giovanna Ghirlanda; Sara M Vaiana
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.